Market OverviewAllergy immunotherapy, hypo-sensitization or desensitization, is a preventive therapeutic treatment for the allergic reactions to various allergens including various drugs, foods, bee venom, house dust mites, and grass pollens. It alters immune system’s reaction by gradually increasing doses of the allergen. Before treatment begins, allergist and patient analyse triggering factors for the allergy symptoms that may involve blood and skin tests to confirm the allergens. The immunotherapy helps in reducing the inflammation, increasing immunological tolerance, offering long-term impact, changing the course of disease and improving quality of the patient’s life.
The rising cases of the allergies are expected to escalate the demand of allergy immunotherapy, leading to high growth of market during the forecast period. As per International Study of Asthma and Allergies in Childhood (ISAAC), around 22.1% of the young children between 13 to 14 years are generally affected by the hay fever. According to the data published by American College of Allergy, Asthma and Immunology (ACAAI), the allergies are sixth leading cause of the chronic illness in the U.S., with annual cost in around USD 18 billion, and over 50 million of the Americans suffer from the allergies each year. There is increase in number of people suffering from various food allergies among both adults and children, globally. Hence, growing burden of these diseases is estimated to aid the demand for new immunotherapies.
Segment OverviewSubcutaneous immunotherapy (SCIT), is most commonly used as well as most effective form of the allergy immunotherapy and is the only treatment accessible that actually changes immune system, making it promising to prevent development of asthma and new allergies. The growing approval of immunotherapy is major factor driving growth of the market.
For instance, in 2018, one of major market players, Stallergenes Greer got approval from theU.S. FDA for the extension of indication for Oralair, allergy immunotherapy sublingual tablet, in order to treat patients of ages 5 to 9 with allergies such as grass pollen-induced rhinitis. Moreover, governments are taking various initiatives to increase awareness about the allergies among population, for instance in January 2018, Ministry and Japanese Society of Allergology opened dedicated website for allergies. Therefore, owing to rising burden of these allergies and awareness among population market is anticipated to witness high growth.
Regional OverviewThe U.S. is anticipated to be largest market around the world. High prevalence of such allergies and strict regulatory guidelines which mandate the allergic testing in all cases of emergency and intensive care are some of factors contributing to growth of the U.S. allergy immunotherapy market. It is projected that one among every six people in America (about 50 million) suffers from some or the other form of allergy, and about 25 million people suffer from respiratory allergies. Between the Americans suffering from the respiratory allergies, almost 10 million suffer from the allergic asthma.
In the U.S., ragweed allergy is primary reason for the hay fever (pollen allergies), and the ragweed pollen production is anticipated to increase by around 65% to 100% by 2085. This is gradually contributing to growth of market studied. Moreover, availability of improved healthcare infrastructure is likely driving the growth of the market.
Competitor overviewThe market is a consolidated market due to the presence of limited major market players. Some of the major market players include Hollister Allergy, Aimmune Therapeutics, Merck KGaA (Allergopharma), Leti Pharma, Stallergenes Greer, ALK-Abello A/S, HAL Allergy Group, Allergy Therapeutics, Biomay AG, and Circassia
Key Players
- Torii Pharmaceutical Co., Ltd.
- ALK-Abello A/S
- Allergy Therapeutics
- Biomay AG
- Allovate, LLC
- HAL Allergy Group
- Hollister Allergy
- Leti Pharma
- Merck KGaA (Allergopharma)
- Stallergenes Greer
Market SegmentationBy Immunotherapy Type
By Allergy Type
- Allergic Rhinitis
- Food Allergy
- Asthma
- Others
By Geography
- North America
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- UAE
- Rest of LAMEA
Research Process
Data Library Research are conducted by industry experts who offer insight on
industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager
and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Primary Research
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary Research
Secondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size Estimation
Both, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
